0001477932-24-001895.txt : 20240405 0001477932-24-001895.hdr.sgml : 20240405 20240405161949 ACCESSION NUMBER: 0001477932-24-001895 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240102 FILED AS OF DATE: 20240405 DATE AS OF CHANGE: 20240405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GALLIGAN JOSEPH J CENTRAL INDEX KEY: 0001198613 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54208 FILM NUMBER: 24826773 MAIL ADDRESS: STREET 1: 333 SOUTH GRAND AVENUE, 18TH FLOOR CITY: LOS ANGELES STATE: CA ZIP: 90071 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BioCorRx Inc. CENTRAL INDEX KEY: 0001443863 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-SPECIALTY OUTPATIENT FACILITIES, NEC [8093] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 900967447 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2390 EAST ORANGEWOOD AVENUE STREET 2: SUITE 500 CITY: ANAHEIM STATE: CA ZIP: 92806 BUSINESS PHONE: (714) 462-4880 MAIL ADDRESS: STREET 1: 2390 EAST ORANGEWOOD AVENUE STREET 2: SUITE 500 CITY: ANAHEIM STATE: CA ZIP: 92806 FORMER COMPANY: FORMER CONFORMED NAME: FRESH START PRIVATE MANAGEMENT, INC. DATE OF NAME CHANGE: 20101115 FORMER COMPANY: FORMER CONFORMED NAME: Cetrone Energy CO DATE OF NAME CHANGE: 20080826 4 1 form4.xml FORM 4 X0508 4 2024-01-02-05:00 false 0001443863 BioCorRx Inc. BICX 0001198613 GALLIGAN JOSEPH J 2390 EAST ORANGEWOOD SUITE 500 ANAHEIM CA 92806 true false true false false Common Stock, par value $0.001 2024-01-02-05:00 4 A false 6173 0 A 232292 D Common Stock, par value $0.001 2024-03-28-05:00 4 A false 5566 0 A 237858 D These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.81. These shares were issued to Mr. Galligan pursuant to a Director Agreement, dated February 16, 2021, by and between BioCorRx Inc. and Mr. Galligan. As compensation for his services, Mr. Galligan shall be issued, upon the last day of each fiscal quarter, provided Mr. Galligan is a member of the Board as of such date, the number of shares of the Company's common stock equivalent to $5,000 as determined based on the average closing price on the three trading days immediately preceding the last day of such quarter. The average closing price on the three trading days immediately preceding the date of this transaction was $0.90. /s/ Joseph J. Galligan 2024-04-05-05:00